Cheaper semaglutide drugs launched in India after patent expiry
NEW DELHI, India: Indian drugmakers have begun launching lower-cost versions of popular diabetes and weight-loss drugs Ozempic and Wegovy after a key patent expiry, sharply reducing treatment costs and intensifying competition in the market.
At least half a dozen companies introduced generic versions of semaglutide, the active ingredient in both drugs, over the weekend, with prices estimated to be about 70 perce